- $244.74bn
- $1.23tn
- $126.85bn
- 65
- 56
- 94
- 84
REG - GS Alpha Enhcd Jpn £ - Net Asset Value(s)
AnnouncementREG - GS Activebeta EME $ - Net Asset Value(s)
AnnouncementREG - GS Green Bond ETF E - Net Asset Value(s)
AnnouncementREG - GS Green Bond ETF $ - Net Asset Value(s)
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Convatec Group PLC Goldman Sachs Group. - Holding(s) in Company
AnnouncementREG - Goldman Sachs & Co. Avadel Pharma plc - Form 38.5b - Avadel Pharmaceuticals plc
AnnouncementREG - Goldman Sachs (EPT) Avadel Pharma plc - Form 38.5b - Avadel Pharmaceuticals plc
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - GS Alpha Enhncd EA $ - Net Asset Value(s)
AnnouncementREG - GS Alpha Enhncd EA£ - Net Asset Value(s)
AnnouncementREG - GS Alpha Enhncd EM $ - Net Asset Value(s)
AnnouncementREG - GS Alpha Enhcd Jpn £ - Net Asset Value(s)
AnnouncementREG - GS Activebeta EME $ - Net Asset Value(s)
AnnouncementREG - GS Green Bond ETF E - Net Asset Value(s)
AnnouncementREG - GS Green Bond ETF $ - Net Asset Value(s)
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Goldman Sachs (EPT) Avadel Pharma plc - Form 38.5b - Avadel Pharmaceuticals plc
AnnouncementREG - Goldman Sachs & Co. Avadel Pharma plc - Form 38.5b - Avadel Pharmaceuticals plc
Announcement